Trimetazidine compounds
US5283246A · kind A · utility
4Cited by
2References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 1992 |
| Grant date | Feb 1, 1994 |
| Priority date | — |
| Expiry date | Sep 17, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/58
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The compounds are substituted trimetazidine useful for the treatment of ischaemic pathologies and peripheral vascular pathology. A compound disclosed is 4-(2,3,4-trimethoxybenzyl)-1-[3-(4-hydroxy-2,3,5-trimethylphenoxy)propyl]p iperazine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.